Jun 28, 2017 7:00 am EDT Pelican Therapeutics, a Subsidiary of Heat Biologics, Receives First Tranche of $15.2 Million CPRIT Grant Award
Jun 05, 2017 7:59 am EDT Heat Biologics Presents Poster on its Phase 2 Trial Evaluating HS-410 at ASCO Annual Meeting
May 11, 2017 7:15 am EDT Heat Biologics Provides Business and Clinical Update for the First Quarter of 2017
Apr 05, 2017 8:00 am EDT Heat Biologics Presents New Preclinical Data from OncoSec Collaboration at the American Association for Cancer Research (AACR) Annual Meeting